Indication
Myocardial Infarction Type 2
1 clinical trial
4 products
Clinical trial
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction (TARGET-Type 2): A Pilot Randomised Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Product
Antiplatelet DrugProduct
AnticoagulantsProduct
Statins